Skip to main content
logo
ARS Pharmaceuticals, Inc. (SPRY)
NASDAQ: SPRY · Real-Time Price · USD
9.81
+0.05 (0.51%)
At close: Jun 15, 2026, 4:00 PM EDT
9.95
+0.14 (1.43%)
Pre-market: Jun 16, 2026, 5:34 AM EDT

ARS Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-197.98-171.38-54.37-34.68-20.24
Depreciation & Amortization
1.481.370.080.070.030.21
Stock-Based Compensation
24.2222.114.539.245.842.83
Other Adjustments
-3.08-3.03-7.25-6.851.48-0
Change in Receivables
-16.92-17.21-8.18---
Changes in Inventories
-13.83-21.99-5.95---
Changes in Accounts Payable
25.0318.8816.41-2.78-10.290.97
Changes in Unearned Revenue
-0.2-0.352.09-3.14-1.32-2.51
Changes in Other Operating Activities
4.970.66-6.19-1.45-1.151.18
Operating Cash Flow
-175.07-170.8713.55-59.27-40.08-17.56
Capital Expenditures
-0.27-0.34-0.56-0.18-0.2-0.06
Purchases of Intangible Assets
-2-7.86-7.5---
Purchases of Investments
-222.4-242.03-356.04-272.01--
Proceeds from Sale of Investments
286307258185--
Investing Cash Flow
55.556.77-106.1-87.18-0.2-0.06
Long-Term Debt Issued
-1.4996.26----
Long-Term Debt Repaid
-----8.68-1.82
Net Long-Term Debt Issued (Repaid)
-1.4996.26---8.68-1.82
Issuance of Common Stock
5.025.683.026.90.570.17
Net Common Stock Issued (Repurchased)
5.025.683.026.90.570.17
Issuance of Preferred Stock
-----54.81
Net Preferred Stock Issued (Repurchased)
-----54.81
Other Financing Activities
0.082.6669.38-198.84-
Financing Cash Flow
102.9104.672.46.9190.7353.16
Net Cash Flow
-15.54-9.5-20.15-139.55150.4635.54
Free Cash Flow
-175.34-171.2112.99-59.44-40.28-17.62
FCF Margin
-177.13%-203.14%14.57%-198137.00%-3060.56%-319.94%
Free Cash Flow Per Share
-1.77-1.740.13-0.62-1.01-0.61
Levered Free Cash Flow
-182.29-76.8113.88-61.83-56.28-22.26
Unlevered Free Cash Flow
-185.23-181.142.91-74.98-48.44-19.65
SEC Filings: 10-K · 10-Q